NDC 50268-128 – Buprenorphine

Buprenorphine Hydrochloride 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC50268-128

Product details

Brand name
Buprenorphine
Generic name
Buprenorphine
Labeler
AvPAK
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA201760
Marketed since
March 19, 2024
Listing expires
December 31, 2027
Pharmacologic class
Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine →

Package NDC codes (1)

Package NDCDescriptionSince
50268-128-1550 BLISTER PACK in 1 BOX (50268-128-15) / 1 TABLET in 1 BLISTER PACK (50268-128-11)Mar 19, 2024

Other Buprenorphine products